As a scientist and entrepreneur, Dr Ashkan Eliasy has dedicated his life to advancing healthcare technologies and democratizing their access. From an early age, he developed a passion for programming, technological capabilities, and entrepreneurship. During two summer placements, while studying structural engineering, he developed a complete software package that was used for biomechanics research involving eye x-rays.
In parallel to working full-time as a senior research associate, Ashkan pursued his MBA and PhD in biomedical engineering, both part-time and simultaneously in 2017 and completed both qualifications in 2.5 years instead of the typical 6 years duration for completing a part-time PhD.
For his MBA dissertation on corporate finance, Ashkan applied AI techniques to predict returns on investments, replacing traditional capital asset pricing models and enhancing corporate funding strategies. After it was published in a peer-reviewed scientific journal, it led him to meet an investor banker, co-found a fintech startup (www.caena.io) and become its CTO from January 2021 to date.
The culmination of this journey has been inventing technologies that advanced eye healthcare; therefore, from January 2023, he is joining the University of Liverpool’s medtech spin-out (www.ocuwell.com) as co-founder and CEO to democratize their access. There he will be introducing disruptive medical devices that are